Ocular Therapeutix™ Reports First Quarter 2020 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Ocular Therapeutix (OCUL) Misses Q1 EPS by 4c, Revenues Miss
May 8, 2020 7:09 AM EDTOcular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.61 million versus the consensus estimate of $2.84 million.
The outlook for Ocular continues to brighten, said Antony Mattessich, President and CEO. As our... More
